Pharmaceutical Technology

DECEMBER 19, 2022

Initially, the companies signed a research collaboration and licensing agreement in 2016 to develop and assess up to two bispecific NK cell engagers. These two molecules are presently being analysed by the research and development (R&D) team of Sanofi, with one currently being evaluated in clinical trials.

Development 264

Development Engineer Clinical Trials Clinical Trials 264

Pharmaceutical Technology

AUGUST 1, 2022

The company will jointly design and analyse messenger ribonucleic acid (mRNA) Covid-19 vaccines in partnership with the NIH unit National Institute of Allergy and Infectious Diseases’ Vaccine Research Center (VRC). In November last year, GreenLight and Samsung Biologics entered a collaboration agreement to manufacture mRNA Covid-19 vaccines.

Vaccine 245

Vaccine Vaccination Development RNA 245

Pharmaceutical Technology

OCTOBER 25, 2022

There are options in the future to possibly apply the worldwide research and development (R&D), manufacturing and marketing expertise of Astellas in gene therapy to AAV gene therapy development programmes of Taysha for genetic ailments of the central nervous system (CNS).

Gene Therapy 264

Gene Therapy Gene Development Genetics 264

Pharmaceutical Technology

DECEMBER 2, 2022

The Department of Biotechnology (DBT) and its PSU, Biotechnology Industry Research Assistance (BIRAC), supported Bharat Biotech in developing the new intranasal vaccine for Covid-19. In the studies, a booster dose of the intranasal BBV154 vaccine was given to the participants who had received licensed Covid-19 vaccines earlier.

Vaccine 217

Vaccine Vaccination Clinical Trials Clinical Trials 217

Pharmaceutical Technology

JANUARY 6, 2023

Dutch biotechnology company Synaffix and Amgen have entered a licensing agreement for the development of next-generation antibody-drug conjugates (ADCs). For four future programmes, Amgen will also have an option for exercising exclusive licenses for research and commercialisation.

Development 130

Development Licensing Licensing Antibody 130

pharmaphorum

SEPTEMBER 29, 2020

Cell therapy research has been built on collaborations amongst scientists and entrepreneurs, providing early proof of concept for modalities thought to be too difficult to commercialise but with a strong potential for patient benefit”.

Research 132

Research Gene Editing Development Gene 132

XTalks

AUGUST 25, 2020

Business as usual is anything but in the COVID-19 era, but as the pharmaceutical and clinical trials industries adjust, the US Food and Drug Administration (FDA) has received an influx of questions regarding site inspections and manufacturing-related queries. Pharmaceutical Manufacturing and Supply Chain Changes.

Manufacturing 89

Manufacturing Clinical Trials Clinical Trials Production 89

Cloudbyz

AUGUST 2, 2022

Premarketing drug studies vs Post- Marketing research. Post-marketing research is a generic term used to describe all activities after drug approval by the regulatory agencies, such as the Food and Drug Administration (FDA). Post market research for monitoring drug safety.

Marketing 97

Marketing Research Trials Clinical Trials 97

pharmaphorum

JANUARY 7, 2021

Problems with tolerability, reimbursement and a complex manufacturing process has pegged back sales of CAR-Ts from earlier expectations, but Yescarta reached $450 million in 2019, and nearly matched figure that in the first nine months of 2020, with Tecartus adding a modest $9 million to the pot.

Research 110

Research Antibody Sales Development 110

BioPharma Reporter

DECEMBER 6, 2021

Australiaâs Noxopharm has in-licensed novel RNA tech developed by Hudson Institute of Medical Research: focusing on RNA drug discovery and mRNA vaccine manufacture via Noxopharmâs subsidiary Pharmorage.

RNA 52

RNA Licensing Licensing Vaccine 52

Pharmaceutical Technology

JULY 20, 2022

Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. . Merck (MSD outside the US) manufactures Lagevrio (molnupiravir) which got the FDA’s backing in December 2021, just a day after Pfizer’s EUA for Paxlovid.

Pharmacy 278

Pharmacy Licensing Licensing Drugs 278

Pharmaceutical Technology

DECEMBER 14, 2022

Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications. Under the deal, Merck will license its VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform.

Gene Therapy 130

Gene Therapy Gene Development Manufacturing 130

Fossil Remedies

AUGUST 31, 2022

The main thing is you should know the different aspects of costs while doing the research about a pharmaceutical company. Another important thing is company registration and DLN (Drug License Number). You will require an agreement and licenses. Minimum Investment to Start a Pharma Manufacturing Company.

Pharma Companies 98

Pharma Companies Licensing Licensing Manufacturing 98

Pharmaceutical Technology

MAY 31, 2023

C4 Therapeutics has entered an exclusive licensing agreement with Betta Pharmaceuticals to develop and commercialise CFT8919 across the greater China region. Betta will be responsible for the development, manufacture and commercialisation of CFT8919 in the licensed territories.

In-Vivo 130

In-Vivo Bioavailability In-Vitro Licensing 130

Pharmaceutical Technology

DECEMBER 6, 2022

Using ExpreS 2 ion’s ExpreS2 platform, the company will manufacture the antigen constructs obtained from RAVEN. According to the agreement, ExpreS 2 ion will hold the exclusive right for licensing the CMV vaccine candidate under a possible development and commercialisation agreement.

Vaccine 130

Vaccine Vaccination Development Immune Response 130

Pharmaceutical Technology

MAY 16, 2023

Emergent will also hand over San Diego, California-based research facilities (focused on the Chikungunya vaccine candidate), a Swiss-based biologics manufacturing facility, and the EU/US-based commercial operations. Following the completion of the deal, Bavarian Nordic now boasts the only oral vaccine licensed by the U.S.

Vaccine 130

Vaccine Vaccination Licensing Licensing 130

Pfizer

JANUARY 27, 2023

Pfizer Responds to Research Claims carterda Fri, 01/27/2023 - 19:48 Pfizer Responds to Research Claims Friday, January 27, 2023 - 08:00pm Share New York, N.Y., In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research.

Research 112

Research Vaccine Vaccination Drugs 112

Pharmaceutical Technology

FEBRUARY 3, 2023

Under the deal, Karuna will have an exclusive worldwide licence for the development, manufacturing, and commercialisation of multiple Goldfinch Bio’s TRPC4/5 candidates, including GFB-887, the lead clinical-stage candidate. Additionally, the company will receive a royalty on net sales of each licensed product.

Licensing 130

Licensing Licensing Sales Development 130

Scienmag

AUGUST 20, 2020

VA seeking companies to license, manufacture Credit: Dr. Scott Fuller/VA SACRAMENTO, Calif. – An ear, nose, and throat doctor has invented a simple mask design that significantly improves safety during aerosol-generating procedures of the head and neck.

Doctor 95

Doctor Doctors Licensing Licensing 95

Pharmaceutical Technology

AUGUST 12, 2022

Mark Samuels, chief executive of the British Generic Manufacturers Association (BGMA) remarked that these duplicative processes would add time and cost. “We It is part of the good manufacturing practice (GMP) quality assurance system, and is undertaken by laboratories, usually at contract research organisations (CROs).

Medicine 290

Medicine Production Generic Drugs Regulation 290

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. As a result, multiple vaccines, including Pfizer /BioNTech’s mRNA vaccine, Comirnaty, were licensed for use within a year of development beginning.

Vaccine 234

Vaccine Vaccination Bacteria Life Science 234

Pharmaceutical Technology

FEBRUARY 3, 2023

Researchers have relentlessly worked through the barriers to create lifechanging treatments for patients in need. “As CAR T based therapies manufactured with lentiviral vectors are also on the rise, points out Clive Glover, PhD, General Manager, Pall Corporation.

Genomics 244

Genomics Genome Medicine Gene Therapy 244

XTalks

JANUARY 22, 2025

IXCHIQ is the only licensed chikungunya vaccine in the US for adults aged 18 and older at increased risk of exposure to the virus. This includes post-marketing studies, label extensions for younger populations and a licensing agreement with the Serum Institute of India to supply the vaccine in Asia at affordable prices.

Immune Response 59

Immune Response Vaccine Vaccination Trials 59

FDA Law Blog

FEBRUARY 5, 2024

HP&M has been helping clients navigate the challenges of state licensing regulations for drugs, biologics, medical devices, OTCs, 503B outsourcing facilities, 503A pharmacies, foods, dietary supplements, cannabis, and wholesalers/distributors for many years. Keup has joined the firm to assist attorneys Karla L.

Licensing 45

Licensing Licensing Pharmacy Regulation 45

The Pharma Data

NOVEMBER 25, 2020

26, 2020 /PRNewswire/ — Cantargia AB (OMXS: CANTA) and BioInvent International AB (OMXS: BINV), today announced that BioInvent has been contracted as manufacturer of Cantargia’s antibody CAN10 in preclinical development for the treatment of systemic sclerosis and myocarditis. LUND, Sweden , Nov. About BioInvent.

Antibody 52

Antibody Manufacturing Clinical Trials Clinical Trials 52

pharmaphorum

JANUARY 5, 2023

Nonetheless, Moderna has previously been involved in licensing deals to advance its technology. Stéphane Bancel, chief executive officer at Moderna, said: “With this acquisition, we obtain best-in-class tools for cell-free synthesis and amplification of plasmid DNA, a key building block in mRNA manufacturing.”.

Gene Sequencing 97

Gene Sequencing DNA Vaccine Vaccination 97

XTalks

MAY 5, 2022

Based on the science from the researchers who established the framework of modern Paleolithic nutrition, the program aims to provide guidance for the food industry by codifying Paleo Diet standards and making them available to manufacturers, retailers and other partners.

Packaging 98

Packaging Packaging Licensing Licensing 98

pharmaphorum

DECEMBER 16, 2020

AbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the therapy in from Harbour BioMed and Utrecht University. AbbVie will conduct clinical development of ABBV-47D11, and if successful, will manufacture and market the product worldwide.

Antibody 98

Antibody Trials Licensing Licensing 98

Pharmaceutical Technology

JUNE 30, 2022

Plus, there is no need to obtain import licenses for IMP and additional approval is needed for comparators, laboratory kits and biosamples. What’s more, the majority of Eastern European Contract Research Organisations (CROs) already have experience in clinical trials in the region as well as registered offices in Georgia.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Licensing 130

XTalks

MARCH 17, 2025

Roche, a global leader in biotechnology and diagnostics, has entered into an exclusive collaboration and licensing agreement with Zealand Pharma, a specialist in innovative therapeutics, to co-develop and co-commercialize petrelintide as a potential foundational therapy for people with overweight and obesity. billion $1.4

Hormones 59

Hormones Drugs Sales Insulin 59

The Pharma Data

JANUARY 13, 2021

Germany-based Cevec Pharmaceuticals GmbH signed a licensing agreement with Biogen for the use of its proprietary ELEVECTA Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications. This product complements Cellectis’ portfolio of technologies involved in manufacturing allogeneic CAR T-cells.

Licensing 52

Licensing Licensing Protein Antibody 52

The Pharma Data

OCTOBER 27, 2021

NYSE and TASE: TEVA) and MODAG GmbH today announced a strategic collaboration on the exclusive worldwide licensing and development of MODAG’s lead compound anle138b and a related compound, sery433. Small molecule candidate Anle138b targets disease modification for multiple system atrophy and other neurological disorders. About MODAG.

Licensing 52

Licensing Licensing Drugs Development 52

BioPharma Reporter

JULY 20, 2023

Twist Bioscience, a biotech company manufacturing synthetic DNA, and Cancer Research Horizons, the innovation engine at the core of Cancer Research UK, have announced an agreement under which Cancer Research Horizons will license the entire Twist Biopharma Solutions Library of Libraries.

Research 40

Research DNA Engineer Licensing 40

Camargo

DECEMBER 13, 2021

Both the FDA’s Center for Drug Evaluation and Research (CDER) and its Center for Biologics Evaluation and Research (CBER) have regulatory responsibility for therapeutic biological products, which are subject to both the Federal Food, Drug and Cosmetic (FD & C) Act and the Public Health Service (PHS) Act.

Development 161

Development Production Immune Response Licensing 161

Drug Channels

MARCH 18, 2025

Pharmacies and PBMs, Examining $683 Billion Market Review pricing/license options and download the full 2025 report Order before March 31, 2025 to receive special discounted pricing! WHATS GOING ON Twice a year, the DCI team researches and writes two comprehensive, fact-based, and nonpartisan reports on drug channel economics.

Pharmacy 52

Pharmacy Licensing Licensing Drugs 52

The Pharma Data

JANUARY 11, 2021

a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, today announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development.

Antibody 52

Antibody Licensing Licensing Development 52

Pharmaceutical Technology

AUGUST 15, 2022

Home to 1,900 life sciences companies, Ontario has a thriving healthcare ecosystem backed by top-ranking research institutions and hospital networks, a highly skilled workforce and a government that supports its continued growth and success. These factors have combined to make Ontario a leading force for medical research and innovation.

Life Science 130

Life Science Research Manufacturing Insulin 130